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Abstract
Background: Due to the high prevalence of depressive disorders, it is mandatory to develop therapeutic strategies that provide
universal access and require limited financial and human resources. Web-based therapeutic approaches fulfill these conditions.
Objective: The objective of our study was to assess the feasibility, acceptability, and efficacy of a supervised, individualized
8-week Web-based exercise intervention conducted for patients with moderate to severe depression.
Methods: We recruited 20 patients with unipolar depression and randomly assigned them into 2 groups (intervention, exercise
program group, n=14, and control, treatment-as-usual group, n=6). At baseline, depressive symptoms were rated via the Quick
Inventory of Depressive Symptomatology (QIDS) by patients themselves (QIDS–self-report, QIDS-SR) and by a blinded
psychiatrist (QIDS–clinician rating, QIDS-C). In addition, performance diagnostics (lactate analysis, spiroergometry during a
treadmill walking test) were conducted. Quality of life was assessed via the Short Form-36 questionnaire (SF-36) and self-efficacy
via the General Self-Efficacy scale (GSE). In addition, habitual physical activity (HPA) was determined via the Baecke
questionnaire. Participants of the intervention group received exercise schedules once weekly with endurance and strength training
instructions. Rating of depressive symptoms was repeated after 6-12 days and 8 weeks; performance diagnostics and the completion
of all the questionnaires were repeated after 8 weeks only.
Results: The severity of depression subsided significantly in the intervention group after 8 weeks (median change in QIDS-SR:
−5; interquartile range, IQR: −2 to −10), although it was already evident within the first 6-12 days (median change in QIDS-SR:
−6; IQR: −2 to −8). During the intervention, participants undertook a median of 75 (IQR: 63 to 98) minutes of endurance training
per week or 84% (16 [IQR: 9 to 19] of 19 [IQR: 15 to 21]) recommended endurance units in total. In addition, 9 (IQR: 4 to 12)
of 10 (IQR: 8 to 13) recommended strength training exercise units were conducted during the 8 weeks. Performance diagnostics
revealed a substantial increase in the maximum output in Watt for the intervention group after 8 weeks. Moreover, the intervention
showed a favorable effect on SF-36 items “emotional well-being” and “social functioning” as well as on GSE and HPA scores.
Conclusions: Our individualized Web-based exercise intervention for moderate to severe depression was highly accepted by
the patients and led to a significant and clinically relevant improvement of depressive symptoms.
Trial Registration: ClinicalTrials.gov NCT02874833; https://clinicaltrials.gov/ct2/show/NCT02874833 (Archived by WebCite
at http://www.webcitation.org/72ZUUR4tE)
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Introduction
Unipolar depression or major depressive disorder (MDD) is the
worldwide leading cause of disability [1] with a life time
prevalence of around 17% [2]. MDD is commonly treated with
either antidepressive medication or psychotherapy or both [3].
However, side effects of and an often skeptical attitude toward
pharmacotherapy lead to poor compliance [4]. In addition, about
30%-50% of patients do not respond adequately to
antidepressants [5,6]. On the other hand, personalized
psychotherapy requires high personal effort, especially for highly
prevalent diseases such as MDD. However, such high personnel
expenses cannot be implemented, especially in rural areas. The
resulting imbalance of supply and demand leads to waiting
periods of several months [7]. Thus, the development of easily
accessible, cost-saving, ubiquitous, and effective treatment
strategies, well accepted by patients, is of great importance in
health politics. In this study, we exploited such an innovative
form of therapy in terms of an individualized, supervised,
Web-based exercise therapy in patients with MDD and moderate
to severe depressive symptoms. We chose this approach because
physical activity is currently recommended as a safe and
effective adjunctive therapy in the treatment of MDD in
numerous national guidelines [8-10].
To the best of our knowledge, this is the first Web-based
exercise approach in the treatment of MDD. Previous Web-based
trials on depression have focused on self-help and cognitive
behavioral therapy (CBT) [11-13]. Meta-analyses assessing the
effectiveness of these interventions on depression severity have
reported variable results [14,15]. However, moderate effects on
depressive symptoms were reported when Web-based CBT was
offered in an individually tailored form [16]. Accordingly, our
Web-based exercise program was monitored and individually
adapted for each patient.
So far, Web-based exercise therapy has been applied to a variety
of patient groups such as type 2 diabetes patients [17,18], breast
cancer survivors [19], or osteoarthritis patients [20]. The
outcomes in the respective studies were promising in terms of
improved blood sugar parameters [18], reduced fatigue [19], or
an enhanced activity level [18-20]. Thus, Web-based exercise
interventions have a remarkable potential for improving
health-related outcomes.
In the last years, exercise has garnered growing interest as a
component in the treatment of depression. Evidence suggests
that exercise may lead to a marked reduction in depressive
symptoms, comparable with pharmacotherapy, after 16 weeks
[5,21]. The latest Cochrane Review [22] reported a moderate
clinical effect of exercise on depressive symptoms. However,
if only studies with high methodological quality were
considered, the effects of exercise were shown to be only small
to moderate, in line with the meta-analysis of randomized
controlled trials by Krogh et al [23] and Josefsson et al [3]. In
contrast, a more recent meta-analysis supported the assumption
of an underestimation of exercise effects on depressive
symptoms due to publication bias [24]. In sum, further
standardized studies are needed to give a robust estimate about
the therapeutic effect size of exercise.
It has not yet been clarified which type, duration, and intensity
of exercise is most effective in depression [22] and whether
there are exercise-specific physiological changes that mediate
antidepressive effects [25]. The specific psychological or
biological mechanisms through which physical activity may
lead to positive effects on depressive symptoms remain a matter
of current research. However, exercise seems to be a promising
adjunctive therapy option for depression, given that there exists
no specific monomodal therapy that is effective in every patient
[21].
In contrast to previous exercise studies on depression [5,26,27],
we developed an individualized Web-based approach that did
not schedule attendance exercise sessions. The purpose of this
study is to evaluate (1) the feasibility and (2) the antidepressive
effects of our Web-based exercise program.
Methods
General Information and Ethics
The multidisciplinary single-center trial was a collaboration
between the Department of Psychiatry and Psychotherapy and
the Institute of Sports Medicine of the University of Mainz. The
study was designed as a feasibility study, which would be
continued with higher sample sizes and under participation of
multiple centers if the study provided promising outcomes. All
procedures were approved by the regional Ethical Board Mainz,
Germany. Previous and ongoing treatment was not affected by
study participation.
Inclusion Criteria
Patients who fulfilled the following criteria were included in
the study:
1. Ability to understand the purpose and risks of the study and
provide signed and dated informed consent and
authorization to use confidential health information in
accordance with national and local subject privacy
regulations
2. Sufficient computer or internet literacy to get along with
our internet platform
3. Aged 20-65 years, inclusive, at the time of informed consent
4. Montreal Cognitive Assessment [28] >18 to exclude
moderate to severe cognitive impairment
5. Apart from a clinical diagnosis of major depression or
bipolar affective disorder, the subject must be in good health
as determined by the investigator based on medical history
and physical examination.
6. Quick Inventory of Depressive Symptomatology (QIDS)
scores >5
7. No changes in antidepressive therapy in the 4 weeks before
study entry
For detailed exclusion criteria, please refer to ClinicalTrials.gov
(NCT02874833).
Participants and Randomization
Participants were recruited offline between July 2016 and
October 2017 through local outpatient psychiatrists. Two
patients disclaimed our offer to participate in the study. A total
of 20 participants with depressive symptoms were enrolled after
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2 of 22 patients were excluded due to myocardial inflammation
and pregnancy. Patients did not receive any compensation for
participating in the study.
For randomization, numbers between 0 and 1 were randomly
computer generated and used for assignment to either the control
group (values ≤.3) or intervention group (IG; values of >.3). At
baseline (T0), depressive symptoms were rated by patients
themselves and by a blinded psychiatrist (SL or CK). Thereafter,
patients were subjected to performance diagnostics (lactate
diagnostics, spiroergometry), which was followed by either an
8-week supervised, individualized Web-based exercise program
(IG) or treatment as usual (control group). Within 6-12 (median:
9) days after T0, the rating was repeated (T1). The final
examination, including clinical rating and performance
diagnostics, took place after 8 weeks (T2). Controls underwent
all examinations, while any other form of existing therapy (eg,
antidepressive medication) was not affected (Figure 1).
Intervention and Internet Platform
IG patients gained access to our home page (Figure 2) and were
provided with a heart rate monitor (Polar FT1; Polar Electro,
Büttelborn, Germany) and 4 different types of resistance bands
(Thera-Band, Akron, OH, United States). The platform was
designed to be user friendly [29]. Message function was used
to send exercise schedules to the patients once weekly. After
each week, motivational feedback was given to improve
adherence [30,31].
Schedules included the recommended extent of exercise with a
maximum of 3 endurance and 2 strength training units per week.
An additional group training session was offered biweekly by
a sports therapist. At the end of each week, patients were
expected to upload a protocol of their weekly activity on our
platform, making the protocol available to the supervisor. Based
on this response, training goals were individually adapted in
the duration and intensity for the following week to keep
motivation high and prevent patients from overload and
frustration.
Structure of Weekly Exercise
Endurance exercise recommendations were based on heart rate
(baseline +1.5 mmol model [32]) with a duration of 30-60
minutes per unit; this has been proven to be effective in the
reduction of depressive symptoms [5,27,30]. However, as
suggested by Craft and Landers [33] and in line with guidelines
[34], it was necessary for some untrained or unexperienced
subjects to start with a more moderate duration of 20 minutes
per session and 2 units per week. Patients with a poor exercise
capacity were recommended to start with walking instead of
jogging. By taking these personal preferences and individual
conditions into account, we aimed at achieving high adherence
[27,30]. Furthermore, adjustment and weekly progression of
the endurance training were assessed via Borg scale [35] (Figure
3) to keep the intensity in a moderate to vigorous range
according to common guidelines and recommendations [8,9,30].
If patients reported Borg values to be <4, training intensity was
moderately increased [36] in terms of an expanded duration of
approximately 10 minutes per week or by recommending a
higher average heart rate, leading to a higher intensity. In case
of fatigue or injury or if exercise was too hard (Borg>7),
intensity and duration were reduced according to patients’
request. In this case, alternative units such as relaxing were
recommended. Furthermore, strength training exercises for
major muscle groups were performed at home following the
detailed instructions provided on our home page. Progression
was ensured with increased sets and repetitions or by changing
the type of resistance band.
Figure 1. Flowchart of the study.
JMIR Ment Health 2018 | vol. 5 | iss. 4 | e10698 | p.3http://mental.jmir.org/2018/4/e10698/
(page number not for citation purposes)
Haller et alJMIR MENTAL HEALTH
XSL•FO
RenderX
Figure 2. Design of our home page with chat and message function, training videos, and upload area for training schedules.
Figure 3. Activity protocol of one participant; patients responded after each week by uploading their filled protocol either as a scan or a Word document.
In this example, intensity and duration of the endurance training was recommend to be increased, whereas the intensity of the strength training was
advised to be decreased.
Evaluation of Primary Outcomes
Adherence
Adherence has been defined as attendance, lack of dropout,
participation rate, or the fulfillment of predefined goals [37].
IG patients dropped out if no protocol was uploaded for >2
weeks. Controls, however, dropped out if they failed to attend
the final examination at T2 [38]. The participation rate in our
exercise program was defined as (1) training units conducted
and (2) the ratio of training units conducted and training units
recommended [21,38]. Data were extracted from the weekly
protocols of participants (Figure 2). All units that did not count
to regular, prescribed strength or endurance exercise, such as
hiking or relaxing, were counted as alternative units. In addition,
after T2, using a self-developed questionnaire among patients,
we evaluated satisfaction with our program and reasons for not
meeting our exercise recommendations.
Depression Scales
The severity of depressive symptoms was determined using
QIDS (clinician rating, QIDS-C, and self-report, QIDS-SR)
[39]. Rating was conducted at baseline, at T1 within 6-12 days,
and after 8 weeks. QIDS scores can range from 0 to a maximum
of 36. QIDS showed good internal consistency (Cronbach
alpha=.86), and QIDS-SR16 total scores highly correlated with
IDS-SR30 (r=.96) and HAM-D24 (r=.86; [39]).
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Evaluation of Secondary Outcomes
Self-Efficacy, Quality of Life, and Habitual Physical
Activity
The Short Form-36 (SF-36) Quality of Life questionnaire [40]
was filled out by every patient at baseline and after 8 weeks.
SF-36 items show high reliability (Cronbach alpha>.85,
reliability coefficient>.75) and construct validity [41]. In
addition, the General Self-Efficacy scale (GSE) [42] and habitual
physical activity (HPA) [43] were assessed at T0 and T2.
Physiological Parameters
After clinical rating and answering questionnaires, all patients
performed a treadmill walking test until exhaustion to determine
peak oxygen uptake (VO2 peak) and lactate threshold. Slope
and velocity were increased stepwise after 3 minutes of walking
at a time, as described elsewhere [36]. Lactate samples were
drawn after every step to determine lactate threshold using the
baseline +1.5 mmol model [32]. Maximum output in Watt was
determined using the formula: 9.81 × weight (kg) × velocity
(m/s) × sin α.
Statistical Methods
For statistical analysis, we used JMP13 (SAS, Cary, NC, USA),
SPSS 23 (IBM, Chicago, IL, USA), and the software package
R, version 3.4.2 (2017-09-28, R Foundation for Statistical
Computing, Vienna, Austria). Differences in baseline
characteristics were examined using Mann-Whitney U test. The
correlation between QIDS-SR and QIDS-C was calculated using
Spearman’s rank correlation coefficient. In addition,
comparisons at different time-points were determined using
Wilcoxon signed-rank test and Bonferroni correction for
multiple testing. To evaluate the influence of the intervention
compared with that of the control condition, analysis of
covariance (ANCOVA) was performed for each outcome. The
outcomes at T2 served as dependent variables and the ones at
T0 as covariates. To exclude a violation of ANCOVA
preconditions, we tested for normal distribution in the residuals
of the dependent variable and for homogeneity of regression
slopes by analyzing the interaction term of independent variable
× covariate. Furthermore, P<.05 was considered as statistically
significant.
For the explorative analysis of the trajectories of the QIDS-SR
and QIDS-C measures, we fit multilevel linear models. Hereby,
the number of training units in the actual number of days in the
program after T0 was used as covariates, and the observations
for individuals were nested in the respective groups, that is,
intervention or control. Furthermore, the log-linear
transformation of the response variables QIDS-SR and QIDS-C
showed better model fit, hinting at an exponential decay over
time. For the covariate analysis, missing data were dealt with
by using the last observation carried forward method. In the
explorative multilevel analysis, missing data were omitted from
the dataset.
Results
Patients’ Characteristics
All patients included were diagnosed with major depression,
none with bipolar affective disorder. Of all, 14 patients were
assigned to the IG, while 6 patients served as controls. Table 1
outlines the clinical characteristics of the patients at baseline.
Of note, 15% (3/20) patients dropped out after T1 and before
T2, which were all IG patients, while all 6 controls completed
the study. Dropouts were because of missing responses for >2
weeks after T1 (Figure 1). Medication did not change over the
course of the study, except for 1 IG subject for whom a dosage
reduction of an antidepressive drug was prescribed by the
treating physician.
At baseline, patients rated their depressive symptoms with a
mean QIDS-SR score of 16, that is, severe depressive symptoms,
whereas QIDS-C was rated slightly lower at 14, representing
moderate depressive symptoms [39]. QIDS-SR and QIDS-C
scores were correlated with each other (r=.64, P<.001). The
mean physical fitness in terms of VO2 peak was determined at
26 mL/min/kg, which matches the predicted values of healthy
subjects, adjusted for sex, age, and weight [44].
Adherence
The dropout rate for IG was 21% (3/14), while all controls
completed the study. In the IG, a median of 75 (interquartile
range, IQR: 63 to 98) minutes of endurance exercise was
performed per week. Overall, 84% (16 [IQR: 9 to 19] of 19
[IQR: 15 to 21]) recommended endurance units were completed.
In addition, patients undertook 90% (9 [IQR: 4 to 12] of 10
[IQR 8 to 13]) recommended strength training units during the
intervention. Four (IQR: 2 to 28) optional, alternative training
units, such as relaxing, hiking, or yoga, were furthermore
executed during 8 weeks. The offer to join group training with
a sports therapist was accepted by 1 patient only.
Self-reported reasons for missing the prescribed training were
as follows: orthopedic problems (n=4), depressive symptoms
(n=4), illness (n=3), or work (n=2). Moreover, our questionnaire
revealed that 9 of 11 patients did not fear any injury, all of the
11 patients saw no risk during exercise, 9 of 11 patients
perceived communication through our platform as “personal,”
and 10 of 11 patients assessed the number of weekly training
instructions as adequate.
Effects on Depressive Symptoms After 8 Weeks
Figure 4 outlines scores of the depression scales QIDS-SR und
QIDS-C at T0 and T2 in both groups. Depressive symptoms
significantly decreased in IG during the 8-week intervention,
as reflected in both QIDS-SR (median change: −5; IQR: −2 to
−10; P=.001) and QIDS-C (median change: −5; IQR: −2 to −7;
P=.02) scores. However, symptom relief was not different to
controls. A reduction in depressive symptoms of ≥50% was
shown via QIDS-SR in 36% (5/14) IG patients and via QIDS-C
in 21% (3/14) IG patients. ANCOVA revealed no statistically
significant difference between the IG and control group.
However, 1 patient in the control group showed a striking
improvement in depressive symptoms from a QIDS-SR score
of 22 at baseline to 2 at T2.
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Table 1. Patients’ characteristics at baseline.
TotalControlsExercise groupCharacteristics
Gender, n (%)
7 (35)3 (50)4 (29)Male
13 (65)3 (50)10 (71)Female
45 (14)51 (12)43 (14)Age (years), mean (SD)
170 (8)168 (7)171 (8)Height (cm), mean (SD)
80 (16)88 (11)77 (17)Weight (kg), mean (SD)
27.0 (5.6)31.3 (4.3)26.5 (5.6)Body mass index (kg/m2), mean (SD)
Depression scores, mean (SD)
16 (3)17 (4)16 (3)QIDS-SRa
14 (3)15 (1)14 (3)QIDS-Cb
26 (2)26 (3)26 (2)Montreal Cognitive Assessment, mean (SD)
Spiroergometry, mean (SD)
26.0 (7.1)23.8 (5.9)27.0 (7.6)VO2 peak
c (mL/min/kg)
112 (42)110 (55)112 (37)Maximum output (Watt)
Treatment at study entry, n (%)
2 (10)0 (0)2 (14)Psychotherapy alone
10 (50)3 (50)7 (50)Psychopharmacotherapy alone
6 (30)3 (50)3 (21)Psychotherapy and psychopharmacotherapy
aQIDS-SR: Quick Inventory of Depressive Symptomatology-self-reported.
bQIDS-C: Quick Inventory of Depressive Symptomatology-clinician-rating.
cVO2 peak: peak oxygen uptake.
Figure 4. Depression scores of the controls and intervention group (IG) on the Quick Inventory of Depressive Symptomatology-self-reported (QIDS-SR;
left) and QIDS-clinician rating (QIDS-C; right) at baseline (T0) and after 8 weeks (T2).
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Figure 5. Depression scores of the controls and intervention group (IG) on the Quick Inventory of Depressive Symptomatology-self-reported (QIDS-SR;
left) and QIDS-clinician rating (QIDS-C; right) at baseline (T0) and after 6-12 days (T1; median: 9 days).
Early Antidepressive Response
Figure 5 shows depression scores of T1 after 6-12 days
compared with the baseline. Depressive symptoms in IG were
significantly reduced, as reflected in both QIDS-SR (median
change: −6; IQR: −2 to −8; P=.003) and QIDS-C (median
change: −3; IQR: −2 to −6; P=.04) scores. ANCOVA showed
an estimated advantage for IG at T1 in the QIDS-SR score of
−3.1 points (coefficient B). However, this effect was not
statistically significant (P=.06; Eta², effect size=0.2). An early
response of >50% reduction was observed for 36% (5/14)
patients in QIDS-SR scores and for 21% (3/14) patients in
QIDS-C scores. A depressive symptom reduction of ≥20% [45]
was observed for 71% (10/14) patients in QIDS-SR scores and
for 50% (7/14) patients in QIDS-C scores, while only 33% (2/6)
controls showed an early response of ≥20% in both the QIDS-SR
and QIDS-C scores.
Self-Efficacy, Quality of Life, and Habitual Physical
Activity
Figure 6 shows the effect of the intervention and treatment as
usual on GSE. ANCOVA revealed a positive influence of the
intervention on SF-36 quality-of-life items “emotional
well-being” (P=.02, Eta2=0.29) and “social functioning” (P=.04,
Eta2=0.23), while the total quality-of-life score (P=.07) and the
item “mental health” (P=.08) showed an estimated advantage.
As expected, IG showed a higher level of physical activity than
controls, reflected in total HPA (P=.007, Eta2=0.36) and HPA
items “leisure time” (P=.02, Eta2=0.27) and “sport” (P=.001,
Eta2=0.51).
Effects on Physiological Performance Parameters
Figure 7 illustrates the physiological parameters in terms of
VO2 peak and maximum output in Watt. IG patients showed an
improvement in VO2 peak of 0.7 mL/min/kg while VO2 peak
of controls declined by 1.6 mL/min/kg. The maximum output
in Watt was improved by 4% in the IG, while that in controls
declined by 9% after 8 weeks. Compared with controls,
ANCOVA revealed no statistically significant influence on the
IG regarding VO2 peak (P=.07) and lactate threshold (P=.09),
but showed a significant influence on the maximum output in
Watt (P=.006; Eta2=0.37; B=14.1).
Explorative Multilevel Analysis
With respect to QIDS-SR, the multilevel analysis showed a
statistically significant effect of day of the measure (estimate:
−0.01 on the log-linear scale, P<.01) and number of training
units (estimate: −0.07 on the log-linear scale, P=.05) as well as
their interaction term (estimate: 0.001 on the log-linear scale,
P=.04). Similar effects could be determined for QIDS-C with
respect to the day of measure (estimate: −0.01 on the log-linear
scale, P<.01) and its interaction term with training units
(estimate: 0.001 on the log-linear scale, P=.05). The number of
training units did not show a statistically significant effect on
QIDS-C (P=.07).
Side Effects of the Intervention
Beside minor orthopedic problems in 4 cases, no side effects
of regular exercise were reported by the patients.
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Figure 6. General self-efficacy scores at T0 (baseline) and T2 (after 8 weeks). Analysis of covariance revealed a favorable effect on the General
Self-Efficacy scale for the intervention group (IG) compared with the controls (P=.02, Eta²=0.28).
Figure 7. Peak oxygen uptake (VO2 peak; left) and maximum output in Watt (right) at baseline (T0) and after 8 weeks (T2) for the intervention group
(IG) and the controls.
Discussion
Principal Findings
Due to the high prevalence, high personnel expenses, and
therapeutic costs of MDD, it is desirable to have therapeutic
strategies at hand that are effective and provide universal access
with limited financial and human resource requirements.
Web-based and computerized therapeutic approaches have been
found to be promising to fulfill these claims [46]. To date, the
focus has been on CBT [11,47] or self-help [12] internet therapy.
Exercise has been suggested as an augmentation or alternative
therapy for depressed patients [9,22]. Here we show for the first
time that an 8-week Web-based exercise intervention with
individualized weekly training schedules is feasible and effective
in patients with moderate to severe depressive symptoms.
Adherence
During the 8-week intervention, patients conducted 84% (16/19)
of recommended endurance units and 90% (9/10) strength
training units, which exceeds [48] or is comparable to the
adherence reported in previous studies regarding attendance
[5,27] or home-based exercise, that is, exercising at home with
regular contact to the supervisor [21].
The depression severity in this study was moderate to severe,
that is, higher than that in previous trials that investigated the
effects of exercise on depressive symptoms [21,26,27].
Christensen et al [38] reported that the probability of adherence
in Web-based therapeutic trials decreases with the severity of
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depression. It is, thus, somewhat surprising that adherence in
this study was comparable to that in previous ones [5,21,27].
The dropout rate in our study was 21% in the IG, comparable
to personalized psychotherapy [49] but probably lower than that
for psychotropic drugs. Up to 50% do not adhere to their
antidepressants [50].
The high therapeutic adherence in our study might partially be
attributed to the preferential recruitment of patients with a
relatively high interest in sports. Our patient sample reached
the predicted VO2 peak values [44], in contrast to the expected
lower physical fitness values in depression [51]. This suggests
that the physical fitness of our participants was
higher-than-average for patients with depression. The
Web-based exercise might, therefore, be a preferred therapeutic
option for patients with depression who were physically active
before the manifestation of the depressive disorder.
Efficacy in Major Depressive Disorder
IG patients showed a significant decline in depressive symptoms
after 8 weeks in both self- and clinician rating. Moreover, the
intervention led to a significant improvement in self-efficacy
and quality-of-life items “emotional well-being” and “social
functioning.”
Interestingly, we had already observed a significant IG response
within 6-12 days of the commencement of the study. Both
QIDS-SR and QIDS-C scores were reduced by ≥50% in 36%
(5/14) and 21% (3/14) patients, respectively. An early reduction
of ≥20% in depressive symptoms was assessed in 71% (10/14)
patients in QIDS-SR scores and in 50% (7/14) patients in
QIDS-C scores, which is comparable to the response rate to
selective serotonin reuptake inhibitors (78%) within the first 14
days of treatment reported in a previous study [45]. However,
the early response rate to selective serotonin reuptake inhibitors,
as described by Tadic et al [45], is likely to be overestimated
as it was evaluated under conditions of inpatient treatment that
entails multimodal therapy with several putative antidepressive
factors.
Because it is unlikely that exercise results in physiological
adaptations within 2 weeks, an early improvement in depressive
symptoms may rather be attributed to the increased self-efficacy
and/or further factors such as personal contact, care, motivation,
ongoing monitoring, and patient expectations toward a positive
effect [21,30], that is, factors that are suggested to contribute
to placebo effects. Early antidepressive effects of exercise may
be mediated by these placebo effects [52], but they may also be
explained by the following: (1) disengaged higher-order
functions of the prefrontal cortex to keep unhelpful emotional
processes from compromising optimal motor execution (transient
hypofrontality hypothesis [53]); (2) the dual-mode theory of
affective responses to exercise [54]; or (3) the opponent-process
theory of emotion [55]. However, even if placebo effects were
mainly responsible for the early positive effects of exercise, this
would not devalue exercise as a therapeutic option because
placebo effects are likely to constitute a large proportion of the
response to antidepressants as well [56].
In contrast to the initial antidepressive effects, the sustained
reduction in depressive symptoms after 8 weeks could be
attributed to physiological adaptations triggered by exercise.
Regular physical activity over several weeks might have
provoked a complex interaction of psychological (eg, increased
self-efficacy) and neurobiological (eg, increased serotonin
synthesis in the brain) adaptations [31]. As the explorative
multilevel analysis revealed, an exponential decay model can
be expected for the treatment. Thus, both a time-function and
the number of training units per time should be included in
future analyses to model the trajectories of the QIDS-SR and
QIDS-C variables.
Comparison to Web-Based Cognitive Behavioral
Therapy
Computerized CBT (cCBT) is highly accepted [57] and has
garnered increasing attention due to its capability to deliver a
potentially effective and efficient therapeutic method to large
numbers of people with depression. However, independent
evaluations of cCBT have failed to prove relevant clinical
benefits in depression [15] unless offered in an individually
tailored form [16]. In this study, depressive symptoms declined
with individualized Web-based exercise therapy. This
therapeutic approach has, thus, a similar potential as individually
tailored cCBT. However, in contrast to cCBT, it has the
advantage of being cognitively little demanding. In this study,
40% of depressive participants showed a Montreal Cognitive
Assessment score of <26, indicating mild cognitive impairment.
In depression, attentional and executive functions are often
affected, which limits the patients’ capability to follow the
cognitive demanding instructions of cCBT. Another advantage
of exercise is its positive influence on cardiovascular risk factors,
the immune system, bone metabolism, and others [58], which
helps prevent somatic disorders such as cardiovascular and
cerebrovascular diseases and type 2 diabetes mellitus [26], to
which patients with chronic depression are more vulnerable
than others. However, a Web-based exercise program has the
disadvantage that people must be motivated and physically able
to perform exercise therapy. This is a particular challenge in
depression because people with depression are, on average,
physically little active [59,60]. Thus, it is likely that
individualized Web-based exercise will be accepted by a
subgroup of depressive patients only. However, patients’
acceptability can be enhanced by starting with a lesser number
of exercise units (2 instead of 3) with individually adapted
moderate intensity and by providing regular motivational
feedback.
Study Limitations
One objective of this study was to evaluate the acceptability of
individualized Web-based exercise therapy and its effects on
depressive symptoms. The study was, thus, designed as it is
appropriate for a feasibility study. Hence, the sample size was
rather small, especially for the control group (n=6). Furthermore,
1 participant in the control group showed full remission at T2
from severe depressive symptoms at study entry, entailing a
probable overestimation of antidepressive effects in the control
group. Thus, comparisons between the intervention and control
groups should be considered as little valid.
Another limitation of this study is its duration of 8 weeks. The
exercise duration of 8 weeks with constant 3 endurance units
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per week usually results in an improvement of all physiological
performance parameters (VO2 peak, lactate threshold, and
maximum output in Watt) [61] On the basis of the results
reported by Blumenthal et al [21], we expected that patients
with MDD would be able to perform constantly 3 endurance
exercises per week. However, most of our patients with MDD
were only capable of starting with 2 endurance units per week.
Thus, our 8-week exercise intervention led merely to a
significant increase in the maximum output in Watt but not in
VO2 peak and lactate threshold. We, hence, recommend
performing regular endurance exercise for, at least, 10 weeks
to achieve an improvement in all physiological performance
parameters in future MDD studies. This is in line with a previous
recommendation for the prescription of exercise in MDD [30].
IG participants performed, on average, 75 minutes of weekly
endurance exercise over the 8 weeks. This only meets the
minimum level of required exercise for both healthy and
depressed subjects [9,34,62], which in combination with the
short intervention may have led to a nonsignificant improvement
of physiological performance parameters. Nonetheless, patients
also benefit from a small amount of physical activity [63].
Follow-up data were not obtained in this feasibility study.
Hence, data on the long-term effects of our exercise intervention
are missing. Follow-up data on the long-term effects of exercise
in MDD are limited in literature, but they indicate a sustained
benefit on depressive symptoms [64,65], with a significant
number of patients continuing exercise on their own [66].
Babyak et al [65] showed that the antidepressive effects of
aerobic exercise were sustained over a follow-up period of 6
months; interestingly, patients in the exercise group had also
significantly lower relapse rates than those in the medication
group during the follow-up.
No study has hitherto examined the effects of a Web-based
exercise intervention. Web-based apps show a trend toward
nonusage over time, including nonavailability for follow-up
[67]. For these reasons and the risk of relapses in depression
[68], we strongly recommend including follow-up measurements
in future studies.
In sum, this study proved that an individualized Web-based
exercise program of 8 weeks is feasible and well accepted. In
addition, the exercise program led to a significant and clinically
relevant improvement of depressive symptoms in the IG.
Expensive performance diagnostics might be dispensable if
exercise starts with only 2 endurance units per week of low
intensity. Furthermore, exercise recommendations for the
upcoming week can then be given on the basis of the
performance in the last week (Figure 3) according to a strict
algorithm.
Moreover, the coherence between self-rated and clinician-rated
depressive symptoms was high. Thus, rating by a physician is
redundant. Regular motivational feedback and goal-setting—key
factors to high adherence, especially in Web-based settings
[12,30,31,38]—can also be generated by a Web-based therapist.
As a consequence, rating of depressive symptoms as well as
exercise recommendations could be given without the
involvement of a physician. If such modifications are
implemented, our exercise program is suitable for full
computerization.
Conclusions and Implications for Further Research
We showed for the first time that an individualized, Web-based
exercise program is feasible and effective in patients with
moderate to severe depression. Our program could be an option
for (1) patients who do not respond to or do not want to apply
pharmaceuticals or psychotherapy and (2) patients who are
motivated and physically able [33] to complete a structured
exercise program over several weeks. In addition, the study
gives important implications for future randomized, fully
computerized, and individually tailored exercise trials in MDD.
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